Pharsight Invited to Present at the Noble Financial Two Double-O-Seven Conference
Share:
MOUNTAIN VIEW, Calif., Aug. 13 / -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services for optimizing clinical drug development, announced today that it will present at the Noble Financial "Two-Double-O-Seven" Conference in Charleston, South Carolina on Monday, August 20, 2007 at 3:30 p.m. Eastern Time. Management will give a presentation discussing the business strategy and financial performance of the Company.
Attendance at the conference is by invitation only. A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Pharsight's website, www.pharsight.com/. An archived replay of the presentation will also be available approximately one hour following the live presentation. The webcast replay may be accessed at www.pharsight.com/.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight is headquartered in Mountain View, California. Information about Pharsight is available at www.pharsight.com/.
Source: Pharsight Corporation
CONTACT:Investors, Jennifer Beugelmans, +1-646-201-5447, or Douglas Sherk, +1-415-896-6820, or Media, Jennifer Saunders, +1-646-201-5431, all of EVC Group, for Pharsight Corporation
Web site: www.pharsight.com
